News Releases

25 Aug '22
SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Aug. 25, 2022-- Quince Therapeutics, Inc. (Nasdaq: QNCX), a biopharmaceutical company advancing innovative precision therapeutics targeting debilitating and rare diseases, announced that the company will present at a number of scientific meetings
13 Jun '22
SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Jun. 13, 2022-- Cortexyme, Inc. (Nasdaq: CRTX), a clinical-stage biopharmaceutical company focused on rare and degenerative diseases, today announced the appointment of June Bray , a pharmaceutical industry veteran and global drug development and
Displaying 1 - 10 of 22